Experience

Davis Polk advised Pactiv Evergreen Inc. (formerly known as Reynolds Group Holdings Limited) on its $574 million initial public offering of 41,026,000 shares of common stock. The shares of…

Davis Polk advised Royalty Pharma plc in connection with its Rule 144A/Regulation S offering of $1 billion aggregate principal amount of its 0.75% senior notes due 2023, $1 billion…

Davis Polk advised the joint book-running managers in connection with an SEC-registered debt offering by Intercontinental Exchange, Inc. of $1.25 billion in aggregate principal amount of…

Davis Polk advised Graham Packaging Company Inc. on a Rule 144A/Regulation S offering of $510 million aggregate principal amount of its 7.125% senior notes due 2028. The notes are…

Davis Polk advised Royalty Pharma plc and the selling shareholders on Royalty Pharma’s $2.5 billion initial public offering of 89,333,920 of its Class A ordinary shares, which included an…

Davis Polk advised the representatives and joint book-running managers of an SEC-registered offering by Black Hills Corporation of $400 million aggregate principal amount of its 2.500%…

Davis Polk advised the placement agent in connection with a private placement pursuant to Rule 4(a)(2) by Humanigen Inc. of $72 million of common stock. Humanigen Inc. is a clinical…

Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the SEC-registered offering by Fiserv, Inc. of $1 billion principal amount…

Davis Polk advised the representatives of the underwriters in connection with a $1 billion SEC-registered debt offering by Campbell Soup Company, consisting of $500 million of its 2.375%…

Davis Polk advised the underwriter in connection with a $100 million SEC-registered underwritten primary block trade of 1,222,942 common shares of Black Hills Corporation. The common shares…